Musculoskeletal News and Research

RSS

VIA Pharmaceuticals announces results of phase 2 trials of VIA-2291 in cardiovascular disease

VIA Pharmaceuticals, Inc. has announced the results of two Phase 2 studies of its lead drug, VIA-2291.

10 Nov 2008

Scientists on a quest to find the right prescription for exercise

Canadian scientists have a plan in the pipeline to explore just why exercise is so beneficial to the body.

9 Nov 2008

We all know physical activity is good for you. But why exactly is it good for you?

What effect does exercise have on the cells and tissues of the body? What do we need to know so that we can use physical activity more effectively to combat chronic diseases such as arthritis, diabetes and heart disease? And what social and psychological factors prevent people from exercising or playing sports?

8 Nov 2008

Canadian study to look at exercise and physical activity

We all know physical activity is good for you. But why exactly is it good for you? What effect does exercise have on the cells and tissues of the body?

5 Nov 2008

Pre-treatment MRI eliminates unnecessary surgery for children with suspected musculosketal infections

Pre-treatment MRI can eliminate unnecessary diagnostic or surgical procedures for children with suspected musculoskeletal infections (septic arthritis and osteomyelitis) according to a study performed at Vanderbilt Children's Hospital in Nashville, TN.

4 Nov 2008

Symptoms of fibromyalgia related to dysfunction in parts of brain where pain is processed

Using single photon emission computed tomography (SPECT), researchers in France were able to detect functional abnormalities in certain regions in the brains of patients diagnosed with fibromyalgia, reinforcing the idea that symptoms of the disorder are related to a dysfunction in those parts of the brain where pain is processed.

4 Nov 2008

As many as 4,600 Australian children affected by juvenile arthritis

Experts say as many as 4,600 Australian children under the age of 16 suffer from juvenile arthritis.

29 Oct 2008

New treatment guidelines for carpal tunnel syndrome

The American Academy of Orthopaedic Surgeons (AAOS) has approved and released an evidence-based clinical practice guideline on "The Treatment of Carpal Tunnel Syndrome."

27 Oct 2008

NanoVibronix receives FDA clearance for PainShield diathermy device

NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.

23 Oct 2008

New obesity drug Tesofensine may have huge potential

According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.

23 Oct 2008

A little exercise prolongs life expectancy for people with heart disease

Exercising once a week can help prolong life expectancy for people with heart disease according to a new study from the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway.

21 Oct 2008

Too many 'sickies' could mean a shorter life

Researchers in Britain say workers who take long spells of sick leave more than once in three years, are at a higher risk of death than their colleagues who take no such absence.

6 Oct 2008

Statin-induced muscle disorders are focus of $2.5 million in grants from NIH

Approximately 200,000 of the 38 million people in the U.S. who take statins to treat high cholesterol may develop life-threatening muscle disease.

2 Oct 2008

Arthritis treatments glucosamine and chondroitin shown to be no better than placebo

According to the latest research, the popular supplements glucosamine and chondroitin sulfate, used to fight arthritis and joint pain, do not seem to work any better than a placebo in slowing the loss of knee cartilage in osteoarthritis.

30 Sep 2008

One million pounds to improve access to physiotherapy

Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).

15 Sep 2008

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Novartis has announced that Gleevec (imatinib mesylate) tablets, (known as Glivec (imatinib) outside the US, Canada and Israel), has been granted priority review status by the US Food and Drug Administration (FDA) as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal stromal tumors (GIST).

27 Aug 2008

Running and regular exercise mean a longer life with fewer disabilities

According to scientists in the U.S. people who keep fit by running when they are middle aged and older, are less likely to become disabled later in life and may live longer.

11 Aug 2008

600,000 Australians afflicted with osteoporosis

According to a new report by the Australian Institute of Health and Welfare (AIHW) and Osteoporosis Australia, more than 600,000 Australians are affected by osteoporosis.

5 Aug 2008

After ankle surgery: mobilise with care

People recover faster after surgery for ankle fracture if they are given a cast or splint that can be removed to let them exercise the ankle, than if their foot is placed in an immobilising plaster cast. If the fracture is stable, then encouraging them to walk soon after surgery is also beneficial.

16 Jul 2008

Resveratrol improves health, but not longevity in aging mice

Scientists have found that the compound resveratrol slows age-related deterioration and functional decline of mice on a standard diet, but does not increase longevity when started at middle age.

3 Jul 2008